8-143567334-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001100878.2(MROH6):​c.2065C>T​(p.Arg689Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000435 in 1,218,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

MROH6
NM_001100878.2 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.05

Publications

0 publications found
Variant links:
Genes affected
MROH6 (HGNC:27814): (maestro heat like repeat family member 6)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.108410895).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MROH6NM_001100878.2 linkc.2065C>T p.Arg689Cys missense_variant Exon 14 of 14 ENST00000398882.8 NP_001094348.1 A6NGR9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MROH6ENST00000398882.8 linkc.2065C>T p.Arg689Cys missense_variant Exon 14 of 14 5 NM_001100878.2 ENSP00000381857.3 A6NGR9

Frequencies

GnomAD3 genomes
AF:
0.0000264
AC:
4
AN:
151404
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000657
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000296
Gnomad OTH
AF:
0.000480
GnomAD4 exome
AF:
0.0000459
AC:
49
AN:
1067288
Hom.:
0
Cov.:
30
AF XY:
0.0000496
AC XY:
25
AN XY:
503948
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22342
American (AMR)
AF:
0.00
AC:
0
AN:
7954
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13624
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25376
South Asian (SAS)
AF:
0.000152
AC:
3
AN:
19792
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21010
Middle Eastern (MID)
AF:
0.00106
AC:
3
AN:
2834
European-Non Finnish (NFE)
AF:
0.0000450
AC:
41
AN:
911722
Other (OTH)
AF:
0.0000469
AC:
2
AN:
42634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000264
AC:
4
AN:
151404
Hom.:
0
Cov.:
32
AF XY:
0.0000406
AC XY:
3
AN XY:
73938
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41350
American (AMR)
AF:
0.0000657
AC:
1
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10438
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000296
AC:
2
AN:
67640
Other (OTH)
AF:
0.000480
AC:
1
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 23, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2065C>T (p.R689C) alteration is located in exon 14 (coding exon 14) of the MROH6 gene. This alteration results from a C to T substitution at nucleotide position 2065, causing the arginine (R) at amino acid position 689 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
6.1
DANN
Benign
0.94
DEOGEN2
Benign
0.0035
T;.;.;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.47
.;.;.;T
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.11
T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.20
N;.;.;.
PhyloP100
-1.0
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.67
N;D;D;D
REVEL
Benign
0.11
Sift
Benign
0.16
T;D;D;D
Sift4G
Uncertain
0.0070
D;D;D;D
Polyphen
0.99
D;.;.;.
Vest4
0.085
MutPred
0.21
Loss of MoRF binding (P = 0.0091);.;.;.;
MVP
0.076
MPC
0.019
ClinPred
0.27
T
GERP RS
0.30
Varity_R
0.058
gMVP
0.10
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1433890195; hg19: chr8-144649504; API